Document Detail

Time and out-of-pocket costs associated with respiratory syncytial virus hospitalization of infants.
MedLine Citation:
PMID:  12641860     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The objective of this study was to quantify time spent plus out-of-pocket costs associated with confirmed respiratory syncytial virus (RSV) hospitalization of infants not prophylaxed against RSV. METHODS: A prospective survey was carried out at multiple tertiary care hospitals in the United States. PATIENTS: The patients consisted of a consecutive sample of infants <12 months, born between 33 and 35 weeks of gestation. One site also enrolled full-term infants hospitalized with confirmed RSV. Daily patient census identified eligible patients. Consenting caregivers of eligible subjects (n=84, 1 refusal) were interviewed on discharge day and by telephone approximately 30 days following discharge regarding time and out-of-pocket costs due to RSV. RESULTS: Total average out of pocket expenses were 643.69 US dollars (range 21-16,867 US dollars; SD 2,403 US dollars) for premature and 214.42 US dollars (range 6-827 US dollars; SD 218 US dollars) (P=.0158) for full-term subjects. Total average economic burden per admission was 4517.07 US dollars for premature and 2135.30 US dollars for full-term infants, including the value of lost productivity but excluding inpatient hospital and physician bills and lost income. Premature infants (n=48) had longer hospital stays (mean 6.9 days; SD 7.5 vs. 3.4 days; SD 2.6 days) (P=.001) with an associated mean total time spent by up to 5 adults of 281.7 hours (range 25-2819.7 hours; SD 465.8 hours) versus a mean of 139.7 hours (range 31.8-561.3 hours; SD 118.1 hours) for term infants (P=.109). Time and out-of-pocket costs continued after discharge. CONCLUSIONS: RSV hospitalization of infants is associated with substantial, previously unmeasured time and monetary losses. These losses continued following discharge. The economic burden on families and society appears heavier for infants born at 33 to 35 weeks of gestation than for full-term infants.
Shelah Leader; Harry Yang; John DeVincenzo; Phillip Jacobson; James P Marcin; Dennis L Murray
Publication Detail:
Type:  Comment; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research     Volume:  6     ISSN:  1098-3015     ISO Abbreviation:  Value Health     Publication Date:    2003 Mar-Apr
Date Detail:
Created Date:  2003-03-18     Completed Date:  2003-05-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  100883818     Medline TA:  Value Health     Country:  United States    
Other Details:
Languages:  eng     Pagination:  100-6     Citation Subset:  IM    
MedImmune, Inc., Gaithersburg, MD 20878, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost of Illness
Costs and Cost Analysis
Financing, Personal
Gestational Age
Hospital Costs*
Infant, Newborn
Infant, Premature
Intensive Care Units, Pediatric
Length of Stay / economics
Prospective Studies
Respiratory Syncytial Virus Infections / economics*
Comment On:
Value Health. 2003 Mar-Apr;6(2):98-9   [PMID:  12641859 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Data...
Next Document:  Economic costs of influenza-related work absenteeism.